Joon Lee
Stock Analyst at Truist Securities
(4.84)
# 78
Out of 5,139 analysts
114
Total ratings
64.6%
Success rate
48.78%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Joon Lee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| JAZZ Jazz Pharmaceuticals | Maintains: Buy | $220 → $230 | $169.41 | +35.77% | 4 | Jan 12, 2026 | |
| ARGX argenx SE | Maintains: Buy | $950 → $1,030 | $800.01 | +28.75% | 14 | Jan 8, 2026 | |
| BMRN BioMarin Pharmaceutical | Maintains: Buy | $80 → $100 | $54.59 | +83.18% | 4 | Dec 23, 2025 | |
| WVE Wave Life Sciences | Maintains: Buy | $36 → $50 | $13.65 | +266.30% | 4 | Dec 15, 2025 | |
| PRAX Praxis Precision Medicines | Maintains: Buy | $360 → $500 | $317.25 | +57.60% | 7 | Dec 8, 2025 | |
| ALKS Alkermes | Maintains: Buy | $50 → $55 | $31.63 | +73.89% | 3 | Nov 17, 2025 | |
| NTLA Intellia Therapeutics | Reiterates: Buy | $25 → $14 | $12.50 | +12.00% | 5 | Nov 10, 2025 | |
| RARE Ultragenyx Pharmaceutical | Maintains: Buy | $100 → $90 | $22.49 | +300.18% | 1 | Nov 5, 2025 | |
| RAPP Rapport Therapeutics | Initiates: Buy | $44 | $26.81 | +64.12% | 1 | Sep 16, 2025 | |
| VRTX Vertex Pharmaceuticals | Maintains: Buy | $520 → $490 | $441.36 | +11.02% | 4 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $86 | $72.48 | +18.65% | 2 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $95 → $75 | $33.92 | +121.11% | 8 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $21 | $12.20 | +72.13% | 6 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $76 → $150 | $34.73 | +331.90% | 8 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $190 → $200 | $177.27 | +12.82% | 5 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $120 | $53.51 | +124.26% | 5 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $3.13 | +475.08% | 1 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $16 | $5.47 | +192.50% | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $36 | $22.70 | +58.59% | 7 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $8 | $2.03 | +294.09% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $17 | $6.78 | +150.74% | 7 | Oct 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $5 | $4.56 | +9.65% | 7 | Sep 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $3.76 | +378.72% | 1 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $280 | $1.36 | +20,488.24% | 1 | Oct 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $27 → $34 | $45.68 | -25.57% | 1 | Mar 16, 2021 |
Jazz Pharmaceuticals
Jan 12, 2026
Maintains: Buy
Price Target: $220 → $230
Current: $169.41
Upside: +35.77%
argenx SE
Jan 8, 2026
Maintains: Buy
Price Target: $950 → $1,030
Current: $800.01
Upside: +28.75%
BioMarin Pharmaceutical
Dec 23, 2025
Maintains: Buy
Price Target: $80 → $100
Current: $54.59
Upside: +83.18%
Wave Life Sciences
Dec 15, 2025
Maintains: Buy
Price Target: $36 → $50
Current: $13.65
Upside: +266.30%
Praxis Precision Medicines
Dec 8, 2025
Maintains: Buy
Price Target: $360 → $500
Current: $317.25
Upside: +57.60%
Alkermes
Nov 17, 2025
Maintains: Buy
Price Target: $50 → $55
Current: $31.63
Upside: +73.89%
Intellia Therapeutics
Nov 10, 2025
Reiterates: Buy
Price Target: $25 → $14
Current: $12.50
Upside: +12.00%
Ultragenyx Pharmaceutical
Nov 5, 2025
Maintains: Buy
Price Target: $100 → $90
Current: $22.49
Upside: +300.18%
Rapport Therapeutics
Sep 16, 2025
Initiates: Buy
Price Target: $44
Current: $26.81
Upside: +64.12%
Vertex Pharmaceuticals
Aug 5, 2025
Maintains: Buy
Price Target: $520 → $490
Current: $441.36
Upside: +11.02%
Jul 29, 2025
Maintains: Buy
Price Target: $80 → $86
Current: $72.48
Upside: +18.65%
Apr 28, 2025
Reiterates: Buy
Price Target: $95 → $75
Current: $33.92
Upside: +121.11%
Apr 9, 2025
Maintains: Buy
Price Target: $65 → $21
Current: $12.20
Upside: +72.13%
Mar 31, 2025
Maintains: Buy
Price Target: $76 → $150
Current: $34.73
Upside: +331.90%
Feb 19, 2025
Maintains: Buy
Price Target: $190 → $200
Current: $177.27
Upside: +12.82%
Feb 12, 2025
Maintains: Buy
Price Target: $100 → $120
Current: $53.51
Upside: +124.26%
Jan 29, 2025
Initiates: Buy
Price Target: $18
Current: $3.13
Upside: +475.08%
Jan 8, 2025
Initiates: Buy
Price Target: $16
Current: $5.47
Upside: +192.50%
Nov 11, 2024
Maintains: Buy
Price Target: $30 → $36
Current: $22.70
Upside: +58.59%
Nov 5, 2024
Maintains: Buy
Price Target: $12 → $8
Current: $2.03
Upside: +294.09%
Oct 22, 2024
Maintains: Buy
Price Target: $12 → $17
Current: $6.78
Upside: +150.74%
Sep 20, 2023
Maintains: Buy
Price Target: $6 → $5
Current: $4.56
Upside: +9.65%
May 10, 2023
Initiates: Buy
Price Target: $18
Current: $3.76
Upside: +378.72%
Oct 20, 2021
Initiates: Buy
Price Target: $280
Current: $1.36
Upside: +20,488.24%
Mar 16, 2021
Upgrades: Buy
Price Target: $27 → $34
Current: $45.68
Upside: -25.57%